{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:07:13Z","timestamp":1790683633060,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T00:00:00Z","timestamp":1168473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T00:00:00Z","timestamp":1168473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.leu.2404523","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T10:36:29Z","timestamp":1168511789000},"page":"427-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts"],"prefix":"10.1038","volume":"21","author":[{"given":"P L","family":"Tazzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Grafone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"McCubrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,11]]},"reference":[{"key":"BF2404523_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","volume":"94","author":"A Bellacosa","year":"2005","unstructured":"Bellacosa A, Kumar CC, Di Cristofano A, Testa JR . Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005; 94: 29\u201386.","journal-title":"Adv Cancer Res"},{"key":"BF2404523_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbapap.2003.11.009","volume":"1697","author":"M Hanada","year":"2004","unstructured":"Hanada M, Feng J, Hemmings BA . Structure, regulation and function of PKB\/AKT\u2013a major therapeutic target. Biochim Biophys Acta 2004; 1697: 3\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"BF2404523_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL et al. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17: 590\u2013603.","journal-title":"Leukemia"},{"key":"BF2404523_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189\u2013218.","journal-title":"Leukemia"},{"key":"BF2404523_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","volume":"4","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB . Exploiting the PI3K\/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988\u20131004.","journal-title":"Nat Rev Drug Discov"},{"key":"BF2404523_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.critrevonc.2004.10.012","volume":"56","author":"B Steffen","year":"2005","unstructured":"Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H . The molecular pathogenesis of acute myeloid leukemia. Crit Rev Oncol Hematol 2005; 56: 195\u2013221.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF2404523_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/sj.leu.2404295","volume":"20","author":"H Lelievre","year":"2006","unstructured":"Lelievre H, Ferrand A, Mozziconacci MJ, Birnbaum D, Delaval B . Myeloproliferative disorders: premalignant, stem cell, G1 diseases? Leukemia 2006; 20: 1475\u20131480.","journal-title":"Leukemia"},{"key":"BF2404523_CR8","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","volume":"102","author":"Q Xu","year":"2003","unstructured":"Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M . Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003; 102: 972\u2013980.","journal-title":"Blood"},{"key":"BF2404523_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/sj.leu.2403220","volume":"18","author":"S Zhao","year":"2004","unstructured":"Zhao S, Konopleva M, Cabreira-Hansen M, Xie Z, Hu W, Milella M et al. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia 2004; 18: 267\u2013275.","journal-title":"Leukemia"},{"key":"BF2404523_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/sj.leu.2403653","volume":"19","author":"VL Grandage","year":"2005","unstructured":"Grandage VL, Gale RE, Linch DC, Khwaja A . PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-\u03baB, Mapkinase and p53 pathways. Leukemia 2005; 19: 586\u2013594.","journal-title":"Leukemia"},{"key":"BF2404523_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.leu.2404203","volume":"20","author":"MA Karajannis","year":"2006","unstructured":"Karajannis MA, Vincent L, Direnzo R, Shmelkov SV, Zhang F, Feldman EJ et al. Activation of FGFR1\u03b2 signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells. Leukemia 2006; 20: 979\u2013986.","journal-title":"Leukemia"},{"key":"BF2404523_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/sj.leu.2404204","volume":"20","author":"K Matkovic","year":"2006","unstructured":"Matkovic K, Brugnoli F, Bertagnolo V, Banfic H, Visnjic D . The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells. Leukemia 2006; 20: 941\u2013951.","journal-title":"Leukemia"},{"key":"BF2404523_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/sj.leu.2404245","volume":"20","author":"AM Martelli","year":"2006","unstructured":"Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C et al. Phosphoinositide 3-kinase\/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 2006; 20: 911\u2013928.","journal-title":"Leukemia"},{"key":"BF2404523_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.leu.2402874","volume":"17","author":"YH Min","year":"2003","unstructured":"Min YH, Eom JI, Cheong JW, Maeng HO, Kim JY, Jeung HK et al. Constitutive phosphorylation of Akt\/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 2003; 17: 995\u2013997.","journal-title":"Leukemia"},{"key":"BF2404523_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/cncr.20947","volume":"103","author":"R Kim","year":"2005","unstructured":"Kim R . Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005; 103: 1551\u20131560.","journal-title":"Cancer"},{"key":"BF2404523_CR16","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1158\/0008-5472.CAN-04-1612","volume":"64","author":"JT Lee Jr","year":"2004","unstructured":"Lee Jr JT, Steelman LS, McCubrey JA . Phosphatidylinositol 3\u2019-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells. Cancer Res 2004; 64: 8397\u20138404.","journal-title":"Cancer Res"},{"key":"BF2404523_CR17","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1038\/sj.onc.1206950","volume":"22","author":"KW Scotto","year":"2003","unstructured":"Scotto KW . Transcriptional regulation of ABC drug transporters. Oncogene 2003; 22: 7496\u20137511.","journal-title":"Oncogene"},{"key":"BF2404523_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.leu.2404023","volume":"20","author":"E Bonhoure","year":"2006","unstructured":"Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T et al. Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 2006; 20: 95\u2013102.","journal-title":"Leukemia"},{"key":"BF2404523_CR19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood.V94.3.1046.415k03_1046_1056","volume":"94","author":"O Legrand","year":"1999","unstructured":"Legrand O, Simonin G, Beauchamp-Nicoud A, Zittoun R, Marie JP . Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood 1999; 94: 1046\u20131056.","journal-title":"Blood"},{"key":"BF2404523_CR20","first-page":"1086","volume":"94","author":"CP Leith","year":"1999","unstructured":"Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1\/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 1999; 94: 1086\u20131099.","journal-title":"Blood"},{"key":"BF2404523_CR21","first-page":"3205","volume":"6","author":"DM van der Kolk","year":"2000","unstructured":"van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE et al. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia. Clin Cancer Res 2000; 6: 3205\u20133214.","journal-title":"Clin Cancer Res"},{"key":"BF2404523_CR22","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1182\/blood-2003-07-2490","volume":"104","author":"D Mahadevan","year":"2004","unstructured":"Mahadevan D, List AF . Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies. Blood 2004; 104: 1940\u20131951.","journal-title":"Blood"},{"key":"BF2404523_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/jcp.20628","volume":"207","author":"I Mantovani","year":"2006","unstructured":"Mantovani I, Cappellini A, Tazzari PL, Papa V, Cocco L, Martelli AM . Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J Cell Physiol 2006; 207: 836\u2013844.","journal-title":"J Cell Physiol"},{"key":"BF2404523_CR24","doi-asserted-by":"publisher","first-page":"15616","DOI":"10.1074\/jbc.M011246200","volume":"276","author":"K Ito","year":"2001","unstructured":"Ito K, Olsen SL, Qiu W, Deeley RG, Cole SP . Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1\/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem 2001; 276: 15616\u201315624.","journal-title":"J Biol Chem"},{"key":"BF2404523_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.leu.2404057","volume":"20","author":"M Nyakern","year":"2006","unstructured":"Nyakern M, Tazzari PL, Finelli C, Bosi C, Follo MY, Grafone T et al. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia 2006; 20: 230\u2013238.","journal-title":"Leukemia"},{"key":"BF2404523_CR26","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/sj.leu.2402236","volume":"15","author":"DM van der Kolk","year":"2001","unstructured":"van der Kolk DM, de Vries EG, Noordhoek L, van den Berg E, van der Pol MA, Muller M et al. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. Leukemia 2001; 15: 1544\u20131553.","journal-title":"Leukemia"},{"key":"BF2404523_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1586\/14737159.4.5.705","volume":"4","author":"T Funato","year":"2004","unstructured":"Funato T, Harigae H, Abe S, Sasaki T . Assessment of drug resistance in acute myeloid leukemia. Expert Rev Mol Diagn 2004; 4: 705\u2013713.","journal-title":"Expert Rev Mol Diagn"},{"key":"BF2404523_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.clim.2003.11.009","volume":"110","author":"PO Krutzik","year":"2004","unstructured":"Krutzik PO, Irish JM, Nolan GP, Perez OD . Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 2004; 110: 206\u2013221.","journal-title":"Clin Immunol"},{"key":"BF2404523_CR29","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/sj.leu.2403859","volume":"19","author":"MR Ricciardi","year":"2005","unstructured":"Ricciardi MR, McQueen T, Chism D, Milella M, Estey E, Kaldjian E et al. Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia. Leukemia 2005; 19: 1543\u20131549.","journal-title":"Leukemia"},{"key":"BF2404523_CR30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/sj.leu.2403845","volume":"19","author":"SM Kornblau","year":"2005","unstructured":"Kornblau SM, Womble M, Cade JS, Lemker E, Qiu YH . Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia. Leukemia 2005; 19: 1550\u20131557.","journal-title":"Leukemia"},{"key":"BF2404523_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.bbrc.2004.06.038","volume":"320","author":"S Uddin","year":"2004","unstructured":"Uddin S, Hussain A, Al-Hussein K, Platanias LC, Bhatia KG . Inhibition of phosphatidylinositol 3\u2019-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. Biochem Biophys Res Commun 2004; 320: 932\u2013938.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF2404523_CR32","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0024-3205(00)01026-2","volume":"68","author":"B Laupeze","year":"2001","unstructured":"Laupeze B, Amiot L, Payen L, Drenou B, Grosset JM, Lehne G et al. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci 2001; 68: 1323\u20131331.","journal-title":"Life Sci"},{"key":"BF2404523_CR33","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/sj.leu.2403032","volume":"17","author":"P Lunghi","year":"2003","unstructured":"Lunghi P, Tabilio A, Dall'Aglio PP, Ridolo E, Carlo-Stella C, Pelicci PG et al. Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts. Leukemia 2003; 17: 1783\u20131793.","journal-title":"Leukemia"},{"key":"BF2404523_CR34","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1210\/en.2006-0325","volume":"147","author":"D Romano","year":"2006","unstructured":"Romano D, Pertuit M, Rasolonjanahary R, Barnier JV, Magalon K, Enjalbert A et al. Regulation of the Rap1\/Raf-1\/Erk-1\/2 cascade and prolactin release by the Pi3k\/Akt pathway in pituitary cells. Endocrinology 2006; 147: 6036\u20136045.","journal-title":"Endocrinology"},{"key":"BF2404523_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI12415","volume":"107","author":"O Bahr","year":"2001","unstructured":"Bahr O, Wick W, Weller M . Modulation of MDR\/MRP by wild-type and mutant p53. J Clin Invest 2001; 107: 643\u2013646.","journal-title":"J Clin Invest"},{"key":"BF2404523_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0959-8049(99)00035-0","volume":"35","author":"Y Fukushima","year":"1999","unstructured":"Fukushima Y, Oshika Y, Tokunaga T, Hatanaka H, Tomisawa M, Kawai K et al. Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer. Eur J Cancer 1999; 35: 935\u2013938.","journal-title":"Eur J Cancer"},{"key":"BF2404523_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1097-2765(00)80140-9","volume":"2","author":"SR Grossman","year":"1998","unstructured":"Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX et al. p300\/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 1998; 2: 405\u2013415.","journal-title":"Mol Cell"},{"key":"BF2404523_CR38","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1182\/blood-2005-01-0178","volume":"106","author":"MS Tallman","year":"2005","unstructured":"Tallman MS, Gilliland DG, Rowe JM . Drug therapy for acute myeloid leukemia. Blood 2005; 106: 1154\u20131163.","journal-title":"Blood"},{"key":"BF2404523_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389200043489199","volume":"5","author":"A Haimeur","year":"2004","unstructured":"Haimeur A, Conseil G, Deeley RG, Cole SP . The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004; 5: 21\u201353.","journal-title":"Curr Drug Metab"},{"key":"BF2404523_CR40","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1038\/sj.onc.1206953","volume":"22","author":"GD Kruh","year":"2003","unstructured":"Kruh GD, Belinsky MG . The MRP family of drug efflux pumps. Oncogene 2003; 22: 7537\u20137552.","journal-title":"Oncogene"},{"key":"BF2404523_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","volume":"14","author":"KM Nicholson","year":"2002","unstructured":"Nicholson KM, Anderson NG . The protein kinase B\/Akt signalling pathway in human malignancy. Cell Signal 2002; 14: 381\u2013395.","journal-title":"Cell Signal"},{"key":"BF2404523_CR42","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/sj.leu.2404217","volume":"20","author":"FE Bertrand","year":"2006","unstructured":"Bertrand FE, Steelman LS, Chappell WH, Abrams SL, Shelton JG, White ER et al. Synergy between an IGF-1R antibody and Raf\/MEK\/ERK and PI3K\/Akt\/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells. Leukemia 2006; 20: 1254\u20131260.","journal-title":"Leukemia"},{"key":"BF2404523_CR43","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1182\/blood-2003-02-0396","volume":"102","author":"RB Walter","year":"2003","unstructured":"Walter RB, Raden BW, Hong TC, Flowers DA, Bernstein ID, Linenberger ML . Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells. Blood 2003; 102: 1466\u20131473.","journal-title":"Blood"},{"key":"BF2404523_CR44","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V89.9.3323","volume":"89","author":"CP Leith","year":"1997","unstructured":"Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323\u20133329.","journal-title":"Blood"},{"key":"BF2404523_CR45","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1038\/sj.onc.1209670","volume":"25","author":"C Billottet","year":"2006","unstructured":"Billottet C, Grandage VL, Gale RE, Quattropani A, Rommel C, Vanhaesebroeck B et al. A selective inhibitor of the p110\u03b4 isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene 2006; 25: 6648\u20136659.","journal-title":"Oncogene"},{"key":"BF2404523_CR46","doi-asserted-by":"publisher","first-page":"41670","DOI":"10.1074\/jbc.M406484200","volume":"279","author":"Z Szentpetery","year":"2004","unstructured":"Szentpetery Z, Kern A, Liliom K, Sarkadi B, Varadi A, Bakos E . The role of the conserved glycines of ATP-binding cassette signature motifs of MRP1 in the communication between the substrate-binding site and the catalytic centers. J Biol Chem 2004; 279: 41670\u201341678.","journal-title":"J Biol Chem"},{"key":"BF2404523_CR47","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/sj.onc.1209201","volume":"25","author":"R Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani R, Serra V, Gyorffy B, Jurchott K, Solf A, Dietel M et al. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 2006; 25: 1743\u20131752.","journal-title":"Oncogene"},{"key":"BF2404523_CR48","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.104.069013","volume":"311","author":"B Tolloczko","year":"2004","unstructured":"Tolloczko B, Turkewitsch P, Al-Chalabi M, Martin JG . LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition. J Pharmacol Exp Ther 2004; 311: 787\u2013793.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF2404523_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1172\/JCI9290","volume":"105","author":"GF Sullivan","year":"2000","unstructured":"Sullivan GF, Yang JM, Vassil A, Yang J, Bash-Babula J, Hait WN . Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. J Clin Invest 2000; 105: 1261\u20131267.","journal-title":"J Clin Invest"},{"key":"BF2404523_CR50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00280-002-0551-2","volume":"51","author":"WP Tsang","year":"2003","unstructured":"Tsang WP, Chau SP, Fung KP, Kong SK, Kwok TT . Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells. Cancer Chemother Pharmacol 2003; 51: 161\u2013166.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF2404523_CR51","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/1097-0142(20001101)89:9<1976::AID-CNCR14>3.3.CO;2-E","volume":"89","author":"S Faderl","year":"2000","unstructured":"Faderl S, Kantarjian HM, Estey E, Manshouri T, Chan CY, Rahman Elsaied A et al. The prognostic significance of p16(INK4a)\/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia. Cancer 2000; 89: 1976\u20131982.","journal-title":"Cancer"},{"key":"BF2404523_CR52","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1182\/blood-2005-02-0553","volume":"106","author":"K Kojima","year":"2005","unstructured":"Kojima K, Konopleva M, Samudio IJ, Shikami M, Cabreira-Hansen M, McQueen T et al. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 2005; 106: 3150\u20133159.","journal-title":"Blood"},{"key":"BF2404523_CR53","first-page":"5762","volume":"58","author":"Q Wang","year":"1998","unstructured":"Wang Q, Beck WT . Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Cancer Res 1998; 58: 5762\u20135769.","journal-title":"Cancer Res"},{"key":"BF2404523_CR54","first-page":"475","volume":"1","author":"G Tiwari","year":"2003","unstructured":"Tiwari G, Sakaue H, Pollack JR, Roth RA . Gene expression profiling in prostate cancer cells with Akt activation reveals Fra-1 as an Akt-inducible gene. Mol Cancer Res 2003; 1: 475\u2013484.","journal-title":"Mol Cancer Res"},{"key":"BF2404523_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1158\/1541-7786.MCR-04-0105","volume":"3","author":"Y Furukawa","year":"2005","unstructured":"Furukawa Y, Sutheesophon K, Wada T, Nishimura M, Saito Y, Ishii H et al. Methylation silencing of the Apaf-1 gene in acute leukemia. Mol Cancer Res 2005; 3: 325\u2013334.","journal-title":"Mol Cancer Res"},{"key":"BF2404523_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<365::AID-IJC15>3.0.CO;2-9","volume":"65","author":"DC Zhou","year":"1996","unstructured":"Zhou DC, Ramond S, Viguie F, Faussat AM, Zittoun R, Marie JP . Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines. Int J Cancer 1996; 65: 365\u2013371.","journal-title":"Int J Cancer"},{"key":"BF2404523_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1053\/beha.2000.0124","volume":"14","author":"P Sonneveld","year":"2001","unstructured":"Sonneveld P, List AF . Chemotherapy resistance in acute myeloid leukaemia. Best Pract Res Clin Haematol 2001; 14: 211\u2013233.","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404523","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:46:13Z","timestamp":1648781173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,11]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF2404523"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404523","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,11]]},"assertion":[{"value":"28 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}